American Factory Tracker
About
PharmaceuticalsMarlborough, MassachusettsAnnounced May 31, 2023

Moderna

See all projects by Moderna →

Moderna's commercial mRNA biomanufacturing facility at 149 Hayes Memorial Drive in Marlborough, Massachusetts. Announced May 2023 as a $91M site acquisition plus $230M+ buildout ($322M+ total), with at least 200 permanent full-time positions across engineering, technical operations, manufacturing, maintenance, quality and process engineering. Prior record ($750M / 500 jobs) reflected a separate Blackstone development-and-commercialization funding agreement for Moderna's flu program, not this facility.

Investment
$322.0M
Permanent jobs announced
200
Status
Under Construction
Expected opening
Jun 1, 2025
Why it matters

The pharmaceuticals context.

Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.

Project record

At a glance

Company
Moderna
Industry
Pharmaceuticals
Location
Marlborough, Massachusetts
Investment
$322.0M
Permanent jobs announced
200
Status
Under Construction
Announced
May 31, 2023
Expected opening
Jun 1, 2025
Added to tracker
Apr 15, 2025
Sources

Official references

  • Primary source
    https://wbjournal.com/article/moderna-expanding-to-marlborough-investing-322m-in-biomanufacturing-facility/
Related

Other projects to know

In Massachusetts
Across Pharmaceuticals
Back to the tracker/projects/moderna-marlborough